Internal Medicine, Endocrinology, Diabetes, & Metabolism · Minneapolis, MN
NPI
1528277100
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
10
Medicare group memberships
Hospitals
5
Hospital affiliations
420 Delaware St SE
Minneapolis, MN, 55455
Phone (612) 625-8960
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
634 services
Medicare patients, 2024
259
Average age 66
Drug cost, 2024
$2.9M
1,430 prescriptions
Company payments, 2025
$234
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tasma Harindhanavudhi was code 99214 (office e&m - established), 100 times for 82 patients. In total Tasma Harindhanavudhi billed 634 services in 49 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 100 | 82 | $92.75 | $9,275 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 98 | 94 | $12.37 | $1,212 |
| 77080 Standard X-ray | Office | 83 | 83 | $38.41 | $3,188 |
| 36415 Venipuncture Blood Collection | Office | 50 | 39 | $8.65 | $433 |
| 99204 Office E&M - New | Office | 32 | 32 | $116.89 | $3,740 |
| 99213 Office E&M - Established | Office | 27 | 26 | $49.92 | $1,348 |
| 84443 Clinical Chemistry | Office | 17 | 15 | $16.46 | $280 |
| 82306 Clinical Chemistry | Office | 17 | 17 | $29.01 | $493 |
| 82565 Clinical Chemistry | Office | 15 | 14 | $5.02 | $75.3 |
| 83036 Blood Count | Office | 15 | 12 | $9.52 | $143 |
| 99203 Office E&M - New | Office | 15 | 15 | $68.45 | $1,027 |
| 82040 Clinical Chemistry | Office | 14 | 14 | $4.85 | $67.9 |
| 84439 Clinical Chemistry | Office | 14 | 12 | $8.84 | $124 |
| 82310 Clinical Chemistry | Office | 14 | 14 | $5.06 | $70.84 |
By year: 2022 $29K for 558 services; 2023 $30K for 593 services; 2024 $26K for 634 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 50 | 39 | $8.65 | $433 |
| 82306 Clinical Chemistry | 17 | 17 | $29.01 | $493 |
| 84443 Clinical Chemistry | 17 | 15 | $16.46 | $280 |
| 82565 Clinical Chemistry | 15 | 14 | $5.02 | $75.3 |
| 83036 Blood Count | 15 | 12 | $9.52 | $143 |
| 82310 Clinical Chemistry | 14 | 14 | $5.06 | $70.84 |
| 84439 Clinical Chemistry | 14 | 12 | $8.84 | $124 |
| 82040 Clinical Chemistry | 14 | 14 | $4.85 | $67.9 |
Medicare prescription drug claims, 2024
In 2024, the drug Tasma Harindhanavudhi prescribed most often to Medicare patients was Levothyroxine Sodium, with 153 prescriptions and refills. In total Tasma Harindhanavudhi wrote 1,430 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 153 | 320 | 33 | $2,114 |
| Mounjaro Tirzepatide | 141 | 173 | 24 | $182K |
| Ozempic Semaglutide | 140 | 240 | 36 | $231K |
| Topiramate Generic | 104 | 211 | 27 | $2,298 |
| Metformin Hcl Er Metformin Hcl | 62 | 174 | 22 | $876 |
| Alendronate Sodium Generic | 58 | 145 | 19 | $877 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 54 | 144 | 19 | $8,630 |
| Methimazole Generic | 37 | 109 | 13 | $622 |
| Testosterone Cypionate Generic | 35 | 47 | Under 11 | $1,108 |
| Synthroid Levothyroxine Sodium | 33 | 80 | Under 11 | $2,461 |
| Jardiance Empagliflozin | 30 | 82 | Under 11 | $46K |
| Trulicity Dulaglutide | 30 | 39 | Under 11 | $37K |
| Glipizide Er Glipizide | 29 | 65 | Under 11 | $456 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 25 | 60 | Under 11 | $2,854 |
| Metformin Hcl Generic | 23 | 70 | Under 11 | $335 |
Brand drugs: 664 claims; generic drugs: 636 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tasma Harindhanavudhi $234 ($234 in general payments such as food, travel and fees) from 2 companies. The largest payer was Medtronic, Inc. with $186.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.